These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36268184)

  • 1. The heart and SARS-CoV-2.
    González-Calle D; Eiros R; Sánchez PL
    Med Clin (Engl Ed); 2022 Nov; 159(9):440-446. PubMed ID: 36268184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heart and SARS-CoV-2.
    González-Calle D; Eiros R; Sánchez PL
    Med Clin (Barc); 2022 Nov; 159(9):440-446. PubMed ID: 35945062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
    Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
    Front Immunol; 2022; 13():859550. PubMed ID: 35386714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.
    Al-Kindi S; Zidar DA
    Transl Res; 2022 Mar; 241():25-40. PubMed ID: 34780967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury.
    Xu SC; Wu W; Zhang SY
    Int J Biol Sci; 2022; 18(7):2703-2713. PubMed ID: 35541905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2 years COVID-19 pandemic-What have we learned?].
    Maisch B; Dörr R
    Herz; 2022 Apr; 47(2):177-193. PubMed ID: 35312833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
    Abdel Moneim A; Radwan MA; Yousef AI
    Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of acute myocarditis and pericarditis during the coronavirus disease 2019 pandemic: comparison with the prepandemic period.
    Aquaro GD; Licordari R; Todiere G; Ianni U; Dellegrotaglie S; Restivo L; Grigoratos C; Patanè F; Barison A; Micari A; Di Bella G
    J Cardiovasc Med (Hagerstown); 2022 Jul; 23(7):447-453. PubMed ID: 35763765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
    Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
    Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems.
    Batta Y; King C; Johnson J; Haddad N; Boueri M; Haddad G
    Front Physiol; 2021; 12():748972. PubMed ID: 35095546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
    Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
    Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers.
    Eiros R; Barreiro-Pérez M; Martín-García A; Almeida J; Villacorta E; Pérez-Pons A; Merchán S; Torres-Valle A; Sánchez-Pablo C; González-Calle D; Pérez-Escurza O; Toranzo I; Díaz-Peláez E; Fuentes-Herrero B; Macías-Álvarez L; Oliva-Ariza G; Lecrevisse Q; Fluxa R; Bravo-Grande JL; Orfao A; Sánchez PL;
    Rev Esp Cardiol (Engl Ed); 2022 Sep; 75(9):734-746. PubMed ID: 34866030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology].
    Sinagra G; Porcari A; Merlo M; Fabris E; Imazio M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
    G Ital Cardiol (Rome); 2022 Jun; 23(6):408-413. PubMed ID: 35674028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges.
    Shah KS; Hale Hammond ME; Drakos SG; Anderson JL; Fang JC; Knowlton KU; Shaw RM
    Future Cardiol; 2021 Oct; 17(7):1277-1291. PubMed ID: 33739142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?
    Carubbi F; Alunno A; Leone S; Di Gregorio N; Mancini B; Viscido A; Del Pinto R; Cicogna S; Grassi D; Ferri C
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.